We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Diagnoses Lung Disease from CT Images as Accurately as Medical Specialists

By HospiMedica International staff writers
Posted on 31 Jul 2022

Doctors have waited a long time for an early means of diagnosing idiopathic pulmonary fibrosis, a potentially fatal disease that can scar a person’s lungs. More...

Except for drugs that can delay the disease’s progression, established therapies do not exist. Since doctors face many difficulties diagnosing the disease, they often have to request a specialist diagnosis. In addition, many of the diagnostic techniques, such as lung biopsy, are highly invasive. These investigative measures may exacerbate the disease, increasing a patient's risk of dying. Now, researchers have developed an artificial intelligence (AI) algorithm that accurately and quickly diagnoses idiopathic pulmonary fibrosis. The algorithm makes its diagnosis based only on information from non-invasive examinations, including lung images and medical information collected during daily medical care.

In order to develop the new technology to diagnose idiopathic pulmonary fibrosis, researchers at Nagoya University (Nagoya, Japan) used AI to analyze medical data collected during normal care from patients undergoing interstitial pneumonia treatment. They found that their AI diagnosed idiopathic pulmonary fibrosis with a similar level of accuracy as a human specialist. Despite finding that their AI performed just as well as experts, the team stress that they do not see it as replacing medical professionals. Instead, they hope that specialists will use AI in medical treatment to ensure that they do not miss opportunities for early treatment. Its use would also avoid invasive procedures, such as lung biopsies, which could save lives.

“Idiopathic pulmonary fibrosis has a very poor prognosis among lung diseases,” said Taiki Furukawa, Assistant Professor of the Nagoya University Hospital. “It has been difficult to diagnose even for general respiratory physicians. The diagnostic AI developed in this study would allow any hospital to get a diagnosis equivalent to that of a specialist. For idiopathic pulmonary fibrosis, the developed diagnostic AI is useful as a screening tool, and may lead to personalized medicine by collaborating with medical specialists.”

Furukawa is excited about the possibilities: “The practical application of diagnostic AI and collaborative diagnosis with specialists may lead to a more accurate diagnosis and treatment. We expect it to revolutionize medical care.”

Related Links:
Nagoya University 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Blood Pressure Monitor
Cuff Blood Pressure Monitor
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.